Bolar Pharmaceutical Co., Inc., Securities Litigation, In re
Decision Date | 10 June 1992 |
Docket Number | D,No. 1340,1340 |
Citation | 966 F.2d 731 |
Parties | Fed. Sec. L. Rep. P 96,824 In re BOLAR PHARMACEUTICAL COMPANY, INCORPORATED, SECURITIES LITIGATION. Donfred BERG, on behalf of himself and all others similarly situated, Robert Kosow, Plaintiffs, Bolar Pharmaceutical Company, Incorporated, Robert Shulman, Larry Raisefield, Jack Rivers, Herman Antonoff, Michael Fedidu, Sidney Stuchin, Defendants, Daniel L. Berger, Esq., Appellee, v. Myron C. GACKENBACH, Objector-Appellant. ocket 91-9382. |
Court | U.S. Court of Appeals — Second Circuit |
John Kennedy Cooper, Summit, N.J. (Edmund B. Raftis, Pfaltz & Woller, P.A., Summit, N.J., Thomas D. White, New York City, of counsel), for objector-appellant.
Daniel L. Berger, New York City (Bernstein Litowitz Berger & Grossmann, of counsel), for appellee.
Before: VAN GRAAFEILAND and PRATT, Circuit Judges, and MUKASEY, District Judge of the District Court for the Southern District of New York, sitting by designation.
Myron C. Gackenbach is a member of the plaintiff class that was certified in this securities class action. He appeals from three November 26, 1991, orders of the United States District Court for the Eastern District of New York, Leonard D. Wexler, Judge, which (1) denied Gackenbach's motion to have himself appointed as a special master for the purpose of examining the plaintiffs' attorneys' fees; (2) awarded appellee attorney Daniel L. Berger the sum of $2,351,694.40 for attorneys' fees (representing a modified total lodestar of $1,469,809 multiplied by a risk enhancement factor of 1.6) and $299,672.98 for expenses; and (3) awarded the law firm of Abbey & Ellis $40,000 for attorneys' fees and expenses.
Gackenbach presents the following issues for our review:
1. Did the district court abuse its discretion in determining the attorneys' fee by multiplying the lodestar figure by a factor of 1.6 to account for the risk inherent in prosecuting the suit?
2. Did the district court abuse its discretion in awarding the plaintiff class's counsel $299,672.98 in expenses?
3. Did the district court abuse its discretion in declining to appoint Gackenbach as special master for the purpose of examining the plaintiff class's counsel's fees?
4. Did the district court abuse its discretion in denying any compensation to Gackenbach, his lawyers, and his consultant, for their work performed in objecting to the fee award?
Berger raises one additional issue for our consideration: whether the appeal is frivolous and should entitle Berger to damages and double costs.
As an initial matter, we note that the scope of our appellate review of attorneys' fee awards is narrow. "Abuse of discretion" is one of the most deferential standards of review; it recognizes that the district court, which is intimately familiar with the nuances of the case, is in a far better position to make certain decisions than is an appellate court, which must work from a cold record. We have long recognized that fee awards and risk-enhancement factors fall into this category. See, e.g., Dague v. City of Burlington, 935 F.2d 1343, 1357-60 (2d Cir.1991), cert. granted, --- U.S. ----, 112 S.Ct. 964, 117 L.Ed.2d 130 (1992).
However, "abuse of discretion" is not the equivalent of "unreviewable". If we are to be satisfied that a district court has properly exercised its discretion, we must be informed by the record of why the district court acted as it did. This is why, in the context of attorneys' fee awards, we have demanded "specific reasons" when a district court departs from the lodestar figure, which is "strongly presumed to be reasonable". Huntington Branch, NAACP v. Town of Huntington, 961 F.2d 1048, 1050 (2d Cir.1992). See also Lewis v. Coughlin, 801 F.2d 570, 576 (2d Cir.1986). Cf. Ginett v. Computer Task Group, Inc., 962 F.2d 1085, 1091-92 (2d Cir.1992) (...
To continue reading
Request your trial-
Rudenko v Costello
...its discretion, we must be informed by the record of why the district court acted as it did. In re Bolar Pharmaceutical Co. Securities Litigation, 966 F.2d 731, 732 (2d Cir. 1992) (per curiam). Accordingly, although we will proceed with review of a district court's decision even where it la......
-
Gierlinger v. Gleason
...the case, its award of attorneys' fees is reviewed only for abuse of discretion. See, e.g., In re Bolar Pharmaceutical Co. Securities Litigation, 966 F.2d 731, 732 (2d Cir.1992) (per curiam). However, reviewable for " 'abuse of discretion' is not the equivalent of 'unreviewable,' " id., and......
-
Murphy v. Lynn
...of discretion. See generally Orchano v. Advanced Recovery, Inc., 107 F.3d 94, 99 (2d Cir.1997); In re Bolar Pharmaceutical Co. Securities Litigation, 966 F.2d 731, 732 (2d Cir.1992) (per curiam). In the present case, Murphy applied for attorneys' fees and expenses in the amount of $95,621.1......
-
Rudenko v. Costello
... ... Marine Bancorporation, Inc., 418 U.S. 602, 616 n. 13, 94 S.Ct. 2856, 41 ... L.Ed.2d 297 (1988) (quoting Albemarle Paper Co. v. Moody, 422 U.S. 405, 416, 421, 95 S.Ct ... In re Bolar Pharmaceutical Co. Securities Litigation, 966 ... ...